1 Introduction to Research & Analysis Reports
1.1 Dolutegravir and Dolutegravir Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dolutegravir and Dolutegravir Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dolutegravir and Dolutegravir Generic Drugs Overall Market Size
2.1 Global Dolutegravir and Dolutegravir Generic Drugs Market Size: 2022 VS 2029
2.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dolutegravir and Dolutegravir Generic Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Dolutegravir and Dolutegravir Generic Drugs Players in Global Market
3.2 Top Global Dolutegravir and Dolutegravir Generic Drugs Companies Ranked by Revenue
3.3 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Companies
3.4 Global Dolutegravir and Dolutegravir Generic Drugs Sales by Companies
3.5 Global Dolutegravir and Dolutegravir Generic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dolutegravir and Dolutegravir Generic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dolutegravir and Dolutegravir Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Dolutegravir and Dolutegravir Generic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Market Size Markets, 2022 & 2029
4.1.2 5mg Tablets
4.1.3 50mg Tablets
4.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
4.2.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
4.2.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
4.2.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
4.3.1 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
4.3.2 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
4.3.3 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Dolutegravir and Dolutegravir Generic Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adult
5.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
5.2.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
5.2.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
5.2.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
5.3.1 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
5.3.2 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
5.3.3 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Dolutegravir and Dolutegravir Generic Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Market Size, 2022 & 2029
6.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue & Forecasts
6.2.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2023
6.2.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2024-2029
6.2.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales & Forecasts
6.3.1 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2023
6.3.2 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales, 2024-2029
6.3.3 By Region – Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.4.2 By Country – North America Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.4.3 US Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.4.4 Canada Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.4.5 Mexico Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.5.3 Germany Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.4 France Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.5 U.K. Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.6 Italy Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.7 Russia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.5.9 Benelux Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.6.3 China Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.4 Japan Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.5 South Korea Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.6.7 India Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.7.2 By Country – South America Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.7.3 Brazil Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.7.4 Argentina Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, 2018-2029
6.8.3 Turkey Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.4 Israel Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
6.8.6 UAE Dolutegravir and Dolutegravir Generic Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 ViiV Healthcare Pty Ltd
7.1.1 ViiV Healthcare Pty Ltd Company Summary
7.1.2 ViiV Healthcare Pty Ltd Business Overview
7.1.3 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.1.4 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 ViiV Healthcare Pty Ltd Key News & Latest Developments
7.2 Emcure Pharmaceuticals
7.2.1 Emcure Pharmaceuticals Company Summary
7.2.2 Emcure Pharmaceuticals Business Overview
7.2.3 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.2.4 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Emcure Pharmaceuticals Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.3.4 Mylan Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Company Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.4.4 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Aurobindo Pharma Key News & Latest Developments
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Summary
7.5.2 Qilu Pharmaceutical Business Overview
7.5.3 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Major Product Offerings
7.5.4 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Qilu Pharmaceutical Key News & Latest Developments
8 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity, Analysis
8.1 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity, 2018-2029
8.2 Dolutegravir and Dolutegravir Generic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Dolutegravir and Dolutegravir Generic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dolutegravir and Dolutegravir Generic Drugs Supply Chain Analysis
10.1 Dolutegravir and Dolutegravir Generic Drugs Industry Value Chain
10.2 Dolutegravir and Dolutegravir Generic Drugs Upstream Market
10.3 Dolutegravir and Dolutegravir Generic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dolutegravir and Dolutegravir Generic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Dolutegravir and Dolutegravir Generic Drugs in Global Market
Table 2. Top Dolutegravir and Dolutegravir Generic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Dolutegravir and Dolutegravir Generic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dolutegravir and Dolutegravir Generic Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dolutegravir and Dolutegravir Generic Drugs Product Type
Table 9. List of Global Tier 1 Dolutegravir and Dolutegravir Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dolutegravir and Dolutegravir Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales, (K Units), 2024-2029
Table 46. ViiV Healthcare Pty Ltd Company Summary
Table 47. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 48. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. ViiV Healthcare Pty Ltd Key News & Latest Developments
Table 50. Emcure Pharmaceuticals Company Summary
Table 51. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 52. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Emcure Pharmaceuticals Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 56. Mylan Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Aurobindo Pharma Company Summary
Table 59. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 60. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Aurobindo Pharma Key News & Latest Developments
Table 62. Qilu Pharmaceutical Company Summary
Table 63. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Product Offerings
Table 64. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Qilu Pharmaceutical Key News & Latest Developments
Table 66. Dolutegravir and Dolutegravir Generic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Dolutegravir and Dolutegravir Generic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Dolutegravir and Dolutegravir Generic Drugs Production by Region, 2018-2023 (K Units)
Table 69. Global Dolutegravir and Dolutegravir Generic Drugs Production by Region, 2024-2029 (K Units)
Table 70. Dolutegravir and Dolutegravir Generic Drugs Market Opportunities & Trends in Global Market
Table 71. Dolutegravir and Dolutegravir Generic Drugs Market Drivers in Global Market
Table 72. Dolutegravir and Dolutegravir Generic Drugs Market Restraints in Global Market
Table 73. Dolutegravir and Dolutegravir Generic Drugs Raw Materials
Table 74. Dolutegravir and Dolutegravir Generic Drugs Raw Materials Suppliers in Global Market
Table 75. Typical Dolutegravir and Dolutegravir Generic Drugs Downstream
Table 76. Dolutegravir and Dolutegravir Generic Drugs Downstream Clients in Global Market
Table 77. Dolutegravir and Dolutegravir Generic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dolutegravir and Dolutegravir Generic Drugs Segment by Type in 2022
Figure 2. Dolutegravir and Dolutegravir Generic Drugs Segment by Application in 2022
Figure 3. Global Dolutegravir and Dolutegravir Generic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dolutegravir and Dolutegravir Generic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dolutegravir and Dolutegravir Generic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Dolutegravir and Dolutegravir Generic Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dolutegravir and Dolutegravir Generic Drugs Revenue in 2022
Figure 9. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Dolutegravir and Dolutegravir Generic Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Dolutegravir and Dolutegravir Generic Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 23. US Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 28. Germany Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 37. China Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dolutegravir and Dolutegravir Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dolutegravir and Dolutegravir Generic Drugs by Region, 2022 VS 2029
Figure 54. Dolutegravir and Dolutegravir Generic Drugs Industry Value Chain
Figure 55. Marketing Channels
※参考情報 ドルテグラビルは、抗ウイルス薬の一種であり、特にHIV(ヒト免疫不全ウイルス)感染の治療に用いられています。この薬は、インテグラーゼ阻害剤と呼ばれるクラスに属しており、HIVの複製過程を妨げることでウイルスの活動を抑制します。ドルテグラビルは、薬剤耐性ウイルスに対しても有効であり、そのため世界中で広く使用されている薬剤です。 ドルテグラビルは、通常、他の抗HIV薬と併用して使用されます。その理由は、単独で使用すると、ウイルスが耐性を持つ可能性があるからです。併用療法により、ウイルスの複製をより効果的に抑制し、治療の成功率を高めることができます。 この薬の主な特徴は、その高い効果と良好な忍容性です。研究によると、ドルテグラビルはHIV感染者のウイルス量を迅速に減少させることが報告されており、治療開始から数か月でウイルス量が検出限界以下に下がることが期待されます。また、副作用も比較的少なく、長期間の使用に耐えることができるため、多くの患者にとって良好な選択肢となります。 ドルテグラビルは、いくつかの形態で利用可能です。錠剤の形で提供されることが一般的で、単独または他の抗HIV薬と組み合わせたもので処方されることがあります。オフラベルでの使用や、特定の病状に応じた適応がある場合もあります。特に、妊婦や授乳中の女性に対する使用については、十分なデータがないため、慎重な判断が求められます。 ドルテグラビルの使用は、特にHIV感染の急増が問題とされる発展途上国において重要です。これらの地域では、感染者数が急増していることから、ドルテグラビルを含む療法が提供されることによって、患者のQOL(生活の質)を向上させ、ウイルスの拡散を抑制することが期待されています。 また、ドルテグラビルは、その効果だけでなく、経済的な側面でも注目されています。通院による医療コストや、薬剤耐性による治療費の増加を抑えることができるため、長期的には医療費の削減にも寄与すると考えられています。従って、ドルテグラビルの普及が進むことで、公衆衛生の向上にもつながると期待されます。 ドルテグラビルの関連技術としては、治療効果を予測するためのバイオマーカーの研究や、新たな抗HIV薬の開発が挙げられます。抗ウイルス治療における個別化医療の進展も、今後の重要な分野となっていると言えるでしょう。特に、遺伝子解析技術を用いて、患者ごとの治療反応を予測し、最適な治療法を選択することが可能になるかもしれません。 最後に、ドルテグラビルに関連するジェネリック医薬品の存在も忘れてはなりません。特許が切れた後、複数の製薬会社がドルテグラビルのジェネリック版を市場に導入しています。これによって、より多くの患者がこの治療法にアクセスしやすくなり、治療の普及が促進されています。ジェネリック薬は通常、オリジナルの薬よりも低価格で提供されるため、経済的な負担を軽減する手段としても有効です。しかし、品質や効果については、厳格な規制が求められ、各国の医薬品管理機関による承認が不可欠です。 ドルテグラビルとそのジェネリック薬は、HIV治療において非常に重要な役割を果たしており、今後もその研究や製品開発が進むことが期待されます。特に、患者のニーズに応じた新たな治療法の開発や、より安全で効果的な治療戦略の確立が求められています。これにより、HIV感染症の制御が一層進むことを願っています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer